Gates Package — page 227
of 1375 pages
← p.226 p.228 → · this page in the original PDF · package
Reference #
G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023
Agreement Type
Effective Date Expiration Dz External Parties
Instituto Nacional de Satde Publica, Program for
the Fight against Sexually Transmitted Diseases,
including HIV
/ AID, University Institute Egas Moniz
*Lead Pl
2019-0969
Research Collaboration Agreement
12/3/2019]
12/3/2022 I (Instituto Universitario Egas Moniz) [PT]
Klaus Strebel
2019-0970
Letter of Intent/MOU
8/23/2019
H Clifford Lane
2019-0991
Gift
10/17/2019]
4/30/2022) Bill & Melinda Gates Foundation (BMGF)
2019-0991
Gift
10/17/2019]
4/30/2022)Bill & Melinda Gates Foundation (BMGF)
GlaxoSmithKline PLC (formerly Glaxo Wellcome
2019-0994 _| Letter of Intent/MOU
11/22/2019
PLC) (GSK) [GB]
2019-1039
Gift
11/12/2019]
12/31/2023} Bill & Melinda Gates Foundation (BMGF)
Mathew Memoli
2019-1050
Research Collaboration Agreement
1/16/2020}
1/16/2023] Mayo Clinic
Patrizia FARCI
French Institute of Health and Medical Research
(INSERM, Institut National de la, University of
2019-1056
Research Collaboration Agreement
2/2/2020}
2/2/2023} Strasbourg (Université de Strasbourg) [FR]
Joseph Marcotrigi
2019-1058
Research Collaboration Agreement
4/22/2020)
4/22/2023) University of Washington
Mathew Memoli
2019-1059
CTA - Clinical Trial Agreement
8/17/2021
NOVAVAX, INC.
Jeffrey Cohen
2019-1066
Research Collaboration Agreement
12/26/2019]
12/26/2022 I Children's National Medical Center (CNMC) [US]
Jeffrey Cohen
2019-1072
Gift
11/15/2019]
9/30/2024 I Bill & Melinda Gates Foundation (BMGF)
Jeffery Taubenber
2019-1072
Gift
11/15/2019]
9/30/2024]Bill & Melinda Gates Foundation (BMGF)
Jeffery Taubenber
2019-1072
Gift
11/15/2019]
9/30/2024] Bill & Melinda Gates Foundation (BMGF)
Jeffery Taubenber
Fred Hutchinson Cancer Research Center (FHCRC)
2019-1099
Research Collaboration Agreement
11/26/2019]
11/26/2022 I[US]
Jeffrey Cohen
2019-1113
Research Collaboration Agreement
11/5/2019}
11/5/2021]Corvus Pharmaceuticals
Steven Holland
2019-1170
CTA - Clinical Trial Agreement
10/15/2019
SCYNEXIS [US]
Alexandra Freema
Leiden University Medical Center (Leids Universitair
2019-1176
Research Collaboration Agreement
2/28/2020]
2/28/2023|Medisch Centrum) [NL]
Leiden University Medical Center (Leids Universitair
2019-1176
Research Collaboration Agreement
2/28/2020)
2/28/2023|Medisch Centrum) [NL]
2019-1197
Gift
12/20/2019}
American Society of Tropical Medicine & Hygiene
2019-1197
Gift
12/20/2019)
American Society of Tropical Medicine & Hygiene
2019-1229
CRADA
9/17/2020}
9/17/2025]IFM Therapeutics
Raphaela Goldbac
2019-1271
Research Collaboration Agreement
3/18/2021|
Regeneron Pharmaceuticals, Inc.
Michael Lenardo
2019-1317
Letter of Intent/MOU
11/13/2019
Centers for Disease Control and Prevention (CDC)
_|Adriana Marques
2019-1323
Research Collaboration Agreement
7/13/2020}
7/14/2023] Adaptive Biotechnologies Corp.
John Kash
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/227
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:exh:00120 | — | attachment | 227 |